We previously showed that plasmin binding to streptokinase is a three-step mechanism with a slow off-rate. Results: Using rapid kinetics and equilibrium binding, we defined the unknown mechanism of plasminogen binding to streptokinase. Conclusion: Encounter complex formation and conformational tightening are weakened in the three-step binding mechanism. Significance: The results define the molecular basis for plasminogen displacement by plasmin in complexes with streptokinase.
The serine proteinase plasmin (Pm) 2 is primarily known for its role in dissolving fibrin thrombi (1) . It also causes cell surface remodeling, signaling, and cancer progression (2) . Proteolytic activation of the zymogen plasminogen (Pg) by tissue plasminogen activator and urokinase-type plasminogen activator differs from conformational activation by the non-enzymatic streptococcal pathogenicity factor streptokinase (SK). We studied SK from Streptococcus dysgalactiae subsp. equisimilis because of its 90% homology with phylogenetic cluster 1SKs from the human host-specific, virulent Streptococcus pyogenes (3) . S. dysgalactiae subsp. equisimilis, which is generally opportunistic in horses, also causes severe human infections such as bacteremia, pneumonia, endocarditis, arthritis, and streptococcal toxic shock syndrome (4, 5) .
The Pg activation mechanism by SK is unique (6 -8) . Stoichiometric binding of SK to Pg and Pm forms catalytically active SK⅐Pg* and SK⅐Pm complexes that bind Pg as a substrate in SK⅐Pg*⅐Pg and SK⅐Pm⅐Pg assemblies and cleave Arg 561 -Val 562 in the Pg protease domain to form Pm (6, 8 -14) . Conformational activation of Pg in the catalytic SK⅐Pg* complex by the molecular sexuality mechanism involves insertion of the NH 2 -terminal Ile 1 -Ala 2 residues of SK into the binding cleft of the Pg protease domain (9, 11, 12, (15) (16) (17) . Ile 1 binds Pg Asp 194 (chymotrypsinogen numbering), causing expression of the substrate-binding site and formation of the oxyanion hole (15, 16, 18, 19) . The mechanism is also valid for conformational prothrombin activation by staphylocoagulase and von Willebrand factor-binding protein from Staphylococcus aureus (20, 21) . This mechanism allows group A and C streptococci to hijack Pg in the human fibrinolytic system by quorum sensing-induced secretion of SK. This results in localized plasmin generation for dissolution of host fibrin barriers and facilitated bacterial spreading (22) (23) (24) (25) .
In our unified model, the conformationally activated SK⅐Pg* complex binds Pg as a substrate and cleaves it to Pm. This is the trigger step in a self-limiting mechanism (6 -8) . After 1 SK eq of Pm is formed, it displaces Pg from the SK⅐Pg* complex to form the tight SK⅐Pm catalytic complex (with dissociation constant (K D ) of 12 pM (26, 27) ) that cleaves the remaining free Pg to Pm in a second catalytic cycle, the bullet cycle (6) . In the SK⅐Pm complex, the three SK ␤-grasp domains rearrange from a beads-on-a-string conformation (28) to a crater surrounding the Pm active site (19) . This forms a novel exosite for substrate Pg binding (19, 26) .
[Glu]Pg, the circulating form of Pg, has an NH 2 -terminal plasminogen, apple, nematode (PAN) module, five kringles (K1-K5) with lysine-binding sites (LBSs), and a COOH-terminal serine protease domain (29 -31) . K1, K2, K4, and K5 bind lysine analogs and small aromatic anionic and cationic ligands (32) . K1, K4, and K5 also bind COOH-terminal lysines on fibrin and other proteins (33) (34) (35) (36) (37) (38) . In the compact [Glu]Pg, the NH 2 -terminal PAN module occupies the LBS on K5, and in this spiral ␣-form, [Glu]Pg activation is inefficient (27, 39 -43) . Cleavage of the 77-residue PAN module by Pm converts [Glu] Pg to [Lys] Pg with a partially extended ␤-conformation that exposes kringle LBSs and is readily activated (6, 44 -47) . Occupying these LBSs with the lysine analog 6-aminohexanoic acid (6-AHA) fully extends [Lys] Pg to the ␥-form (39, 43) . SK binds weakly to [Glu] Pg in the absence and presence of 6-AHA, whereas SK binding to [Lys] Pg is tighter due in part to the interaction of the COOH-terminal Lys 414 residue of SK with exposed LBSs on kringle domains in [Lys]Pg (48) . This interaction is weakened ϳ13-20-fold by blocking the LBSs with 6-AHA (27, 48) . 6-AHA binds isolated kringles K1, K4, and K5 (30, 32, 49, 50) , whereas benzamidine binds K1, K2, and K5 (32, 51, 52) and only partially extends [Glu] Pg and [Lys]Pg to the ␤-conformation (39, 43) . K4 and K5 of [Glu] Pg were shown to bind 6-AHA cooperatively (53) , which may be of importance in interpreting differences in binding of SK lysines to Pg and Pm. In this study, we used 6-AHA and benzamidine to study differential effects of LBS occupation on the formation of a stabilized SK⅐Pg complex.
Allosteric linkage between the protease active site and its exosite(s) allows investigating equilibrium binding of ligands to serine proteases labeled at their active sites with fluorescent probes (54 -56) . Active site labeling of the conformationally activated zymogens plasminogen and prothrombin (27, 57) provides the advantage of studying ligand binding uncoupled from catalytic activity. Introducing the fluorescent label 5-fluorescein ([5F]) and a tripeptide chloromethyl ketone in the Pm active site (FFR-Pm) does not affect the affinity for SK, whereas labeled [Glu]Pg and [Lys]Pg analogs bind SK with ϳ5-fold lower affinity than the native proteins (26, 48, 58) . We compared the binding kinetics of labeled Pg and Pm that have their active sites similarly locked in a substrate-binding conformation by the tripeptide chloromethyl ketone.
Here we explore for the first time the steps on the pathway of SK binding to Pg and identify critical differences with Pm binding (59) that are the basis for the ϳ4,000-fold lower affinity of [5F]FFR-[Lys]Pg for SK (27) . Stopped-flow kinetics of SK binding to labeled [Lys]Pg and [Glu]Pg defined the forward reactions of complex stabilization. Reverse reactions were studied by competitive displacement of labeled [Lys]Pg by active siteblocked FFR-Pm in the complex with SK. Forward and reverse reactions were biexponential, and overall off-rates were fast, requiring stopped-flow monitoring. Parameters from numerical integration of full forward and reverse time traces were consistent with those from the SK dependences of the forward rates of these conformational changes. This approach allowed a comparison of the elementary reaction steps in the sequence of SK⅐Pg* and SK⅐Pm formation. The data support a three-step mechanism of encounter complex formation followed by two tightening conformational steps as shown previously for SK⅐Pm (59) but with dramatic decreases in affinity of the encounter complex and ϳ10 -40-fold increases in off-rates for both conformational steps. 
EXPERIMENTAL PROCEDURES
Protein Purification and Characterization- [Glu] Pg carbohydrate form 2 was purified from human plasma and activated to [Lys]Pg and [Lys]Pm (Pm) as described (8, 26, 27, 60, 61) . Pm was purified by affinity chromatography on soybean trypsin inhibitor-agarose and dialyzed against 5 mM HEPES, 0.3 M NaCl, 10 mM 6-AHA, 1 mg/ml PEG 8000 at pH 7.0 and 4°C. The active Pm concentration (ϳ90%) was determined by active site titration with fluorescein mono-p-guanidinobenzoate (62) . Pm (10 -15 M) was covalently inactivated with a 5-fold molar excess of D-Phe-Phe-Arg-CH 2 Cl (FFR-CH 2 Cl) in 0.1 M HEPES, 0.3 M NaCl, 1 mM EDTA, 10 mM 6-AHA, 1 mg/ml PEG 8000, pH 7.0 buffer at 25°C for 30 -60 min until hydrolysis of D-Val-LeuLys-p-nitroanilide was undetectable. Excess inhibitor was removed by dialysis against Ͼ250 volumes of 50 mM HEPES, 0.3 M NaCl, 1 mM EDTA, pH 7.0 at 4°C. Native SK (nSK; Diapharma) was purified from outdated therapeutic SK from the S. dysgalactiae subsp. equisimilis strain H46A (26, 27) . Recombinant wild-type SK (WT-SK) and the SK⌬K414 and SK⌬(R253-L260)⌬K414-His 6 mutants were prepared as published (48, 63) . Proteins were quick frozen in 2-propanol/dry ice and stored at Ϫ80°C. Protein concentrations were determined by absorbance at 280 nm using the following absorption coefficients ((mg/ml) Ϫ1 cm Ϫ1 ) and molecular weights: [Glu]Pg, 1.69 and 92,000; [Lys]Pg, 1.69 and 84,000; Pm, 1.9 and 84,000 (47, 61, 64) ; SK and SK⌬K414, 0.81 and 47,000 (65, 66) ; SK⌬(R253-L260)⌬K414-His 6 , 0.78 and 49,213 (63) .
Active Site Labeling of Pg- [Glu] Pg and [Lys]Pg were labeled at the active site as described previously (27, 58, 63) . The SK⌬(R253-L260)⌬K414-His 6 mutant activates [Lys]Pg conformationally, but the complex does not readily cleave Pg to Pm, and the use of this SK construct for Pg labeling significantly increased the yield of labeled Pg and reduced the preparation time (63) . Labeled Pg concentration and probe incorporation (ϳ90%) were determined from the probe and protein absorbances in 6 M guanidine as described (48, 54, 55) . Proteins were homogeneous by SDS gel electrophoresis.
Stopped-flow Kinetics of nSK, WT-SK, and SK⌬K414
Binding to [5F]FFR-Pg-Complete progress curves of SK binding to labeled Pg were captured with an Applied Photophysics SX-18MV stopped-flow spectrofluorometer in single mixing mode with excitation at 500 nm and an emission cut-on filter (Melles-Griot) with 50% transmission at 515 nm. Changes in fluorescence intensity were measured for all the reactions, and for the interaction of native SK with [5F]FFR-[Lys]Pg in the absence of lysine analogs, changes in fluorescence anisotropy were also monitored. The reaction volume was 200 l, the path length was 2 mm, and experiments were performed at 25°C. Binding was studied under pseudo-first-order conditions (SK Ն5-fold over labeled Pg) in 50 mM HEPES, 0.125 M NaCl, 1 mM EDTA, 1 mg/ml PEG 8000, 1 mg/ml bovine serum albumin, 1 M FFR-CH 2 Cl, pH 7.4 in the absence and presence of 50 mM 6-AHA or in 50 mM HEPES, 0.075 M NaCl, 1 mM EDTA, 1 mg/ml PEG 8000, 1 mg/ml bovine serum albumin, 1 M FFR-CH 2 Cl, pH 7. Subtracting background scattering was critical as the signal-tonoise ratio for reactions with [5F]FFR-Pg (ϳ25% quench and ϳ7.5% maximal scattering) was up to 5-fold smaller than that for reactions with [5F]FFR-Pm (ϳ50% quench and ϳ6% maximal scattering) (59) . Experiments were limited to labeled Pg concentrations up to 20 nM due to the lower solubility of the SK⅐Pg complex compared with that of SK⅐Pm, which resulted in a substantial increase in background scattering at Pg concentrations above ϳ40 nM. None of our previously published studies of SK binding and kinetics have used [ FFR-Pg (10 nM) was titrated with SK or SK⌬K414 at 25°C in 50 mM HEPES, 0.075 M NaCl, 1 mM EDTA, 1 mg/ml PEG 8000 buffer, pH 7.4 containing 50 mM benzamidine, 1 mg/ml BSA, and 1 M FFR-CH 2 Cl. Fluorescence titrations were performed with a Photon Technology International, Inc. fluorometer at excitation and emission wavelengths of 500 and 516 nm, respectively, with 2/8-nm excitation/emission band passes. Fluorescence changes were measured after equilibration for 5-10 min. Measurements were corrected for background (Յ10%) by subtraction of blanks lacking [5F]FFR-Pg. Data were analyzed by the quadratic equation for binding of a single ligand (55) . This analysis gave the dissociation constant (K D ) for binding of SK or SK⌬K414 to [5F]FFR-Pg and the maximum fluorescence intensity change (⌬F max /F o ) with a stoichiometric factor (n) of 1 for binding of SK or SK⌬K414 to labeled Pg.
Two-exponential time traces of forward and reverse reactions, SK dependences of k obs 1,2 , and equilibrium binding of SK and SK⌬K414 to [5F]FFR-Pg in benzamidine buffer were analyzed by nonlinear least square fitting with SCIENTIST Software (MicroMath). All reported estimates of error represent Ϯ2 S.D. SK ϩ Pg L | ;
Numerical Integration Analysis of the Forward and Reverse
The mechanism included Scheme 1 for three-step SK⅐[5F]FFR-Pg binding and Scheme 2 for competitive three-step SK⅐FFR-Pm binding. The dissociation constants K 1 and K 4 for formation of the SK⅐Pg 1 and SK⅐Pm 1 encounter complexes represent the ratios k Ϫ1 /k 1 and k Ϫ4 /k 4 where k 1 and k 4 are the second-order association rate constants and k Ϫ1 and k Ϫ4 are the first-order rate constants for dissociation of the encounter complex. K 1 , k 2 , k Ϫ2 , k 3 , and k Ϫ3 in this mechanism are equivalent to K 1 , k lim 1 , k off 1 , k lim 2 , and k off 2 , respectively, in Equation 2. The threestep mechanism for SK⅐Pm stabilization was validated in a previous study (59) . Time traces of fluorescence quenches were transformed to increases by plotting ⌬F/F o expressed as functions of the formation and stabilization of SK⅐Pg 1, SK⅐Pg 2, and SK⅐Pg 3 complexes using positive amplitude factors as KinTek Explorer does not accept negative parameters. The set of fluorescence anisotropy increases was analyzed without transformation. The fractional change in fluorescence intensity or anisotropy was expressed as (59) .
The large scattering background introduced variable uncertainty in the amplitude factors f 2 and f 3 for [SK⅐Pg 2] and [SK⅐Pg 3] at increasing SK concentrations, resulting in non-random residuals when imposing global f 2 and f 3 fits on the complete data sets. Initial estimates of the rate constants obtained by global fitting of f 2 and f 3 were fixed, and individual f 2 and f 3 amplitude factors were assigned as fitted parameters for time traces at each SK concentration. This largely eliminated the non-random deviations. Subsequent fixing of all the individual amplitude parameters provided further refinement of the fitted rate constants with only subtle differences from the original estimates.
The overall K D values for the final, stabilized complexes were calculated from Equation 3 using the rate constants obtained by numerical analysis and compared with K D, overall obtained independently from equilibrium binding. Fig. 2 shows the nSK and WT-SK dependences in the absence of effectors. The hyperbolic dependences of k obs 1 and the much smaller k obs 2 , respectively, indicated saturation of the encounter complex and the subsequent conformational intermediate (Fig. 2, inset) . The parameters K 1 , k lim 1 , k lim 2 , k off 1 , and k off 2 obtained by fitting the binding rate constants by Equation 2 are given in Table 1 (Table 1 , superscript b). Time traces of the forward reactions of SK binding were not resolvable into two phases and appeared as single exponential curves, whereas SK⌬K414 binding was clearly biphasic. Progress curves for binding of SK and SK⌬K414 and their concentration dependences of k obs 1 and k obs 2 in benzamidine are shown in Fig. 6 . The limiting rate k lim 1 in benzamidine was ϳ5-fold faster for SK binding and ϳ2.3-fold faster for SK⌬K414 binding compared with the values in 6-AHA and in the absence of lysine analogs (Table 1, superscript b) . The ϳ30% lower maximal fluorescence changes than those for equilibrium binding in the presence of benzamidine described below (Table 1) may be due to the scattering properties of Pg complexes in benzamidine being differentially affected by the optical cell geometry and path length of the Photon Technology International, Inc. fluorometer and the stopped-flow instrument. Table 1 for the reactions with nSK and WT-SK, respectively.
RESULTS

Stopped-flow Kinetics of SK Binding to [5F]FFR-[Lys]Pg-
Stopped-flow Kinetics of SK Binding to [5F]FFR-[Glu]PgBiexponential binding of SK to [5F]FFR-[Glu]
Pg was not saturable, and the k 2 /K 1 ratios in the absence and presence of 6-AHA were indistinguishable and similar to those for [5F]FFR-[Lys]Pg binding to SK⌬K414 in the absence of kringle ligands and to nSK and SK⌬K414 binding in 6-AHA (Fig. 7) . Fitting of these near linear dependences was performed using fixed, lower limit K 1 values that were reasonably resolvable by numerical integration (see below). The limiting rate constants k lim 1 and k lim 2 and the off-rates k off 1 and k off 2 were similar to those for SK and SK⌬K414 binding to [5F]FFR-[Lys]Pg in the absence of lysine analogs and in 6-AHA (Table 1, Table 1 . Experiments were performed and analyzed as described under "Experimental Procedures." (Fig. 10) . Analysis of the titrations indicated that SK bound with a K D of 200 Ϯ 20 nM and ⌬F max /F o of Ϫ30 Ϯ 1%. The affinity was ϳ5-fold weaker than in the absence of kringle ligands but still ϳ3-fold tighter than in 6-AHA. SK⌬K414 bound labeled [Lys]Pg with a ⌬F max /F o of Ϫ38 Ϯ 1% and K D of 800 Ϯ 100 nM. This affinity was similar to that of SK in 6-AHA, SK⌬K414 with and without 6-AHA (48) , and SK binding to [5F]FFR-[Glu]Pg with and without 6-AHA (27, 48) .
Numerical Integration Analysis of the Forward and Reverse Reactions-Fitted values for K 1 , the rate constants for both conformational steps, and the fluorescence amplitudes were in good agreement with those obtained from two-exponential analysis and equilibrium binding and are given in Table 1 (superscript a, fluorescence intensity, and superscript aa, fluorescence anisotropy). The results indicated that formation of fluorescently silent SK⅐Pg 1 occurs in the dead time of the reaction and that subsequent partitioning occurs between SK⅐Pg 2 and SK⅐Pg 3.
The SK⅐[5F]FFR-[Lys]Pg encounter complex was weakened ϳ10 -20-fold by blocking LBSs on the Pg kringles and by loss of Lys 414 . The rate constant k 2 for the first conformational step ranged from 25 to 45 s Ϫ1 in the absence and presence of 6-AHA Table 1 . Experiments were performed and analyzed as described under "Experimental Procedures." Table 1 . Experiments were performed and analyzed as described under "Experimental Procedures."
but increased substantially in benzamidine, suggesting a decrease in conformational restraint. The rate constants k Ϫ2 and k Ϫ3 for the reverse reactions were equivalent to k off 1 and k off 2 from hyperbolic fitting of the SK dependences of the forward reaction rates and to k disp 1 and k disp 2 for the biexponential appearance of free [5F]FFR-[Lys]Pg in competitive displacement by FFR-Pm. The analytical solution of the overall k off value for a three-step reaction is only straightforward under conditions of single exponential kinetics (70) ; however, the agreement of k off 2 and k disp 2 with k Ϫ3 from numerical analysis suggests that dissociation is limited by k Ϫ3 . The off-rates were unaffected by lysine analogs.
In Within global data sets, the errors in the amplitude factors f 2 for the fast conformational step and f 3 for the slow step were ϳ30 and ϳ18%, respectively (2 ϫ S.D.). Numerical integration fits for the forward and reverse reactions are shown as colored lines in the figures.
DISCUSSION
The present study demonstrates a minimal three-step sequential mechanism for binding of SK to [5F]FFR-Pg, consisting of an encounter complex with affinity in the low micromolar range followed by at least two resolvable conformational Table 1 . Experiments were performed and analyzed as described under "Experimental Procedures." Table 1 . Experiments were performed and analyzed as described under "Experimental Procedures." steps ( Fig. 11) , which increase the affinity of the stabilized complex to ϳ30 -86 nM. The first conformational step is the main tightening event, whereas the second step does not confer additional tightening. However, deletion of this second step in the mechanism resulted in single exponential curves that did not fit the data.
We previously discovered that a three-step mechanism also governs SK binding to labeled plasmin but with ϳ4,000-fold tighter K D, overall values of 7-12 pM (59). The conformational changes caused a ϳ9,000-fold tightening of the Pm encounter complex but only a ϳ50-fold increase in affinity for Pg. We show here that substantial decreases in affinity of the encounter complex and the second conformational event are mainly responsible for the weaker SK binding to Pg in the stabilized complex.
The results suggest that the SK interactions with LBSs on [Lys]Pg are mainly limited to SK Lys 414 binding to K4, whereas Table  1 . Fluorescence titrations were performed and analyzed as described under "Experimental Procedures." Binding to Pg also involves insertion of the NH 2 terminus of SK in the activation pocket of the Pg catalytic domain; however, adding a conformational step to the mechanism did not improve the fits. Stopped-flow fluorescence of SK binding to labeled Pg may not allow identifying the timing of the NH 2 -terminal insertion or whether NH 2 -terminal insertion contributes to the affinity of the Pg complex, and further studies are required to resolve this complex event.
Binding Benzamidine blocks kringles K1, K2, and K5 and leaves kringle K4 available for lysine binding. The affinity of the SK⅐Pg encounter complex in 6-AHA and benzamidine was similar, suggesting that Lys 414 binding to K4 in Pg does not increase the affinity when K5 is blocked. However, the SK⅐Pm encounter complex was ϳ2-fold tighter in benzamidine than that in 6-AHA and was further weakened by deletion of Lys 414 (59) . Further studies are required to clarify these different effects on Pg and Pm binding.
The 42-residue COOH-terminal sequence is not resolved in the SK⅐Pm crystal structure (19) . Lys 414 at the end of this disordered, mobile sequence may guide the pathway by initial interaction with the LBS on K4; however, this does not contribute much to the free energy of binding of the encounter complex. Calculating changes in free energy of association for SK and SK⌬K414 binding to Pg and Pm from ⌬G 0 ϭ RT ln(K D ) using averaged K 1 values from Table 1 and our previous study (59) shows that the non-LBS interactions contribute ϳ83 and ϳ73% of the binding energy in Pg and Pm encounter complex formation, respectively. SK Lys 414 contributes ϳ17 and ϳ13%. Binding of (an)other SK lysine residue(s) to Pm contributes ϳ14%. Although LBS interactions are important for efficient docking of SK, it appears that non-LBS interactions are the major source of the binding energy both for Pg and for Pm encounter. Previous equilibrium binding studies with ␣-domain-truncated SK showed that the LBS-independent interactions with the Pg/Pm protease domain largely reside in the SK ␣-domain, whereas the ␤-and ␥-domains participate in LBSdependent interactions with Pg/Pm kringles (71) . It is likely that Pm-binding lysines other than the C-terminal Lys 414 reside in the SK ␤-and ␥-domains.
SK⅐Pg and SK⅐Pm differ in their rate constants for the two conformational steps. The k 2 values for the SK⅐Pm complex were ϳ10 s Ϫ1 for intact and Lys 414 -deleted SK and ϳ37 s Ϫ1 in 6-AHA (59); the latter is comparable with k 2 for all the SK and SK⌬K414 interactions with Pg in this study except those in benzamidine. For SK⅐Pm, the conformational restraint reflected by a low k 2 may be due to binding of a non-COOHterminal SK lysine to K5, which also makes the SK⅐Pm encounter complex tighter. This restraint is absent in [Lys]Pg, suggesting no binding contribution from SK lysines other than Lys 414 . Benzamidine enhanced k 2 by 5-and 6-fold in SK binding to Pg and Pm, respectively (59) . This enhancement was weaker with SK⌬K414, suggesting that Lys 414 binding to K4 may release conformational restraints. The large k 2 value may contribute to a ϳ4-fold tighter K D, overall for SK⅐Pg in benzamidine compared with that for SK⅐Pg in 6-AHA and SK⌬K414⅐Pg in all buffer systems. 6-AHA causes transition of [Glu] Pg from the compact ␣-form to the fully extended ␥-form and of [Lys] Pg from the partially extended ␤-to the ␥-form, whereas benzamidine keeps [Lys]Pg in the ␤-form (43) . This suggests that the release of constraints on k 2 does not depend on ␣ 3 ␤ 3 ␥ conformational changes in Pg. The k Ϫ2 , k 3 , and k Ϫ3 values were similar in all data sets, indicating that these steps are LBS-independent.
In summary, we demonstrate here for the first time that the three-step kinetic model for the pathway of Pg binding to SK is substantially different from that of Pm binding with the main differences being a weaker encounter complex and increased off-rates for the conformational steps. Whereas cooperative Lys 414 and other lysine interactions with K4 and K5 and non-LBS interactions with the protease domain contribute to formation of the SK⅐Pm complex, the SK⅐Pg* complex assembly appears to be driven by non-LBS interactions and by SK Lys 414 binding to Pg kringle K4. Consistent with the experimentally determined K m of Ն2 M for substrate Pg binding to the SK⅐Pg* complex and of 270 nM for Pg binding to the SK⅐Pm complex (7) and in the absence of a crystal structure of the SK⅐Pg* complex, we hypothesize that the weaker interaction with Pg in the catalytic complex results in expression of a pro-exosite that binds substrate Pg with lower affinity than the corresponding exosite on the SK⅐Pm complex.
Differences in affinity of the SK⅐Pg* and SK⅐Pm complexes may be important in their partitioning on bacterial surface proteins and in binding to host fibrin(ogen). Group A streptococcal M-like surface proteins bind Pg with high affinity, and the M1 subset lacking Pm-binding motifs binds fibrinogen (Fbg). This allows indirect activation by way of SK⅐Pg*⅐Fbg ternary complex formation (7, 77) , which proceeds by Fbg binding to the SK⅐Pg* complex rather than SK recruitment on the Pg⅐Fbg complex (7). Group A Streptococcus SK exhibits significant polymorphism (78 -80) , and considerable differences exist among SK allelic variants in their efficiency of activating Pg and their recruitment in complexes with Fbg, Fbg fragment D, fibrin, and the plasminogen-binding group A streptococcal M protein (81) .
[Glu]Pg binds fibrin(ogen) through a K1 interaction, whereas K1 and K4 of [Lys]Pg and Pm are involved in fibrin(ogen) binding (74) , and these differences are expected to influence localization of SK⅐Pg* and SK⅐Pm complexes. Future stopped-flow studies will identify how fibrin(ogen) and streptococcal surface proteins affect the pathways of SK⅐Pg* and SK⅐Pm formation and will be instrumental in characterizing these pathways in complexes with allelic SK variants.
